Stay updated on Lazertinib Combination in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lazertinib Combination in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    New update dates appear in December 2025 (2025-12-05, 2025-12-04, 2025-12). November 2025 entries were removed; no changes to the core study details.
    Difference
    0.1%
    Check dated 2025-12-12T16:15:38.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2; no substantive study content changes are present. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T06:09:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.1 on the page.
    Difference
    0.0%
    Check dated 2025-11-21T02:17:41.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a new recruitment site in Tainan, Taiwan (704) and updated the location listings with recent timestamps (2025-11-07 and 2025-11-06).
    Difference
    0.3%
    Check dated 2025-11-13T22:52:13.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The Study Record shows a new last update date (2025-10-10) with minor formatting adjustments; core study information remains unchanged.
    Difference
    0.2%
    Check dated 2025-10-30T14:47:24.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Updated time-related references to current dates (adds October 2025 dates, removes September 2025 dates).
    Difference
    0.2%
    Check dated 2025-10-16T08:36:51.000Z thumbnail image

Stay in the know with updates to Lazertinib Combination in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.